Morimatsu is excited to invite you to the 2024 7th Biopharmaceutical Process Development Conference. This leading industry event, which covers the entire lifecycle of biopharmaceuticals from process development to commercial production, will take place on August 9-10 at the Zhangjiang Science Hall in Shanghai.

The conference is dedicated to advancing biopharmaceutical processes, with a strong focus on innovation and development. We will bring together industry experts and top suppliers to collaborate on advancing biopharmaceutical products, enhancing product quality, optimizing processes, and reducing production costs.

Exhibition Time
August 9-10

Exhibition Venue
Zhangjiang Science Hall, Pudong New District, Shanghai

Morimatsu’s Booth No.
T032

Morimatsu is at the forefront of biotechnology, continuously focusing on cutting-edge technological advancements. With a commitment to innovation and adaptability, we address the diverse needs of our customers across all stages—from R&D to process optimization to commercial production. At this conference, we will showcase our single-use systems, glass bioreactors, and tangential flow filtration systems. We’re excited to share our latest achievements, connect with industry peers, and discuss emerging trends.

We warmly invite you to visit us!
Together, let’s advance the development of the biopharmaceutical industry.
Looking forward to seeing you in Shanghai!

About Morimatsu LifeSciences

Morimatsu LifeSciences, one of the key business segments of Morimatsu International Holding Co., Ltd. (Morimatsu International, stock code: 2155.HK), mainly consists of Shanghai Morimatsu Pharmaceutical Equipment Engineering Co., Ltd., Morimatsu (Suzhou) LifeSciences Company Limited, Shanghai Morimatsu Biotechnology Co., Ltd., Pharmadule Morimatsu AB (Sweden) and its subsidiaries, which serves the pharmaceuticals, bio-pharmaceutical, cosmetic medicine, FMCG (cosmetics, baby, women & home Care, health care, fabric & home care, food, beverage, nutraceuticals) and other industries, providing customers with "core equipment+value-added services+digital intelligent overall factory solutions and services" ("MVP Solutions&Services"), focusing on core equipment, stainless steel process systems, disposable process systems, consumables, laboratory solutions, digital and modular factory solutions and services.

As a diversified multinational company, Morimatsu has opened subsidiaries or advanced manufacturing plants in China, Japan, Sweden, United States, India, Italy, Singapore, and has delivered different forms of products and services to more than 40 countries and regions so far, by its global footprint of an efficient and professional team.

Forward-Looking Statements

The information in this press release may include some forward-looking statements. Such statements are essentially susceptible to considerable risks and uncertainties. The use of "predicted", "believed", "forecast", "planned" and/or other similar words/phrases in all statements related to our company is to indicate that the statements are forward-looking ones. Our Company undertakes no obligation to constantly revise such predicted statements.

Forward-looking statements are based on our Company management's current perspectives, assumptions, expectations, estimations, predictions and understanding of future affairs at the time of the making of such statements. Such statements are not guarantees of future development and are susceptible to the impact of risks, uncertainties and other factors; some are beyond the control of our Company and unpredictable. Subject to the influence of future changes and development in our business, competition environment, political, economic, legal and social conditions, the actual outcomes may differ significantly from the information contained in the forward-looking statements.